- Investing Ideas
- Egyptian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Egyptian Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
1
1 new
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
1 companies